Cart
sales@molnova.com
Brain injury Derived Neurotrophic Peptide(3) BINP
CAS No. ———
Brain injury Derived Neurotrophic Peptide(3) BINP( ——— )
Catalog No. M40905 CAS No. ———
Brain injury Derived Neurotrophic Peptide(3) BINP
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBrain injury Derived Neurotrophic Peptide(3) BINP
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrain injury Derived Neurotrophic Peptide(3) BINP
-
DescriptionBrain injury Derived Neurotrophic Peptide(3) BINP
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1388.58
-
Molecular FormulaC62H101N17O19
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Flecainide hydrochlo...
Flecainide is a medication used to prevent and treat abnormally fast heart rates.?This includes ventricular and supraventricular tachycardias.
-
BAY 2416964
BAY 2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1 (example 192, IC50: 341 nM). It has the potential for cancer treatment.BAY 2416964 induces AHR-regulated gene CYP1A1 expression in human monocytic U937 cells (IC50: 4.3 nM).
-
MMP-1 Substrate I, f...
MMP-1 Substrate I, fluorogenic
